EGFR and cervical squamous cell carcinoma: Cervical squamous cell carcinoma frequently exhibits EGFR overexpression, and the chemotherapeutic agents administered (nab-paclitaxel plus nedaplatin) likely suppressed tumor proliferation and factor secretion, thereby indirectly inhibiting cutaneous signaling activation.